HK Stock Market Move | Joinn Laboratories (06127) fell nearly 10% at one point. Shareholders intend to sell off their A shares of the company in a clearing-type reduction.

date
10:32 17/03/2026
avatar
GMT Eight
New medicine (06127) fell nearly 10% this morning, but the decline has narrowed. As of the time of reporting, it has fallen by 4.21%, at 18.21 Hong Kong dollars, with a trading volume of 83.8033 million Hong Kong dollars.
Joinn Laboratories (06127) fell by nearly 10% this morning, but the decline has since narrowed. As of the time of writing, it is down 4.21% to HKD 18.21, with a turnover of 83.8033 million Hong Kong dollars. On the news front, on the evening of March 16, Joinn Laboratories announced that its shareholder Gu Xiaolei and its concerted action person Gu Meifang plan to clear out their A-share holdings in the company. Specifically, Gu Xiaolei and Gu Meifang currently hold 20.4205 million shares and 10.322 million shares of the company's A-shares, respectively, with shareholding ratios of approximately 2.73% and 1.38% respectively. Shareholder Gu Xiaolei and its concerted action person Gu Meifang plan to reduce their holdings by 20.4205 million shares and 10.322 million shares through centralized bidding on the Shanghai Stock Exchange within three months after the announcement of the reduction plan, totaling 30.7425 million shares, accounting for 4.1% of the company's current total share capital.